Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayode Ogungbenro

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|January 9, 2009
Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial resultsMarylore Chenel, François Bouzom, Fanny Cazade, et al.
The AAPS Journal|November 6, 2015
Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical DataThierry Wendling, Nikolaos Tsamandouras, Swati Dumitras, et al.
Clinical Pharmacology and Therapeutics|September 16, 2017
Dose Rationalization of Pembrolizumab and Nivolumab Using Pharmacokinetic Modeling and Simulation and Cost AnalysisKayode Ogungbenro, Alkesh Patel, Robert Duncombe, et al.
The AAPS Journal|April 29, 2025
Simultaneous Estimation of fm and F<sub>G</sub> Values Directly from Clinical Drug-Drug Interaction Study DataYumi Cleary, Nicolo Milani, Kayode Ogungbenro, et al.
The AAPS Journal|May 16, 2025
Publisher Correction: Simultaneous Estimation of fm and FG Values Directly from Clinical Drug-Drug Interaction Study DataYumi Cleary, Nicolo Milani, Kayode Ogungbenro, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 13, 2005
Optimal blood sampling time windows for parameter estimation using a population approach: design of a phase II clinical trialMarylore Chenel, Kayode Ogungbenro, Vincent Duval, et al.
Pharmaceutical Research|November 27, 2014
Model-based evaluation of the impact of formulation and food intake on the complex oral absorption of mavoglurant in healthy subjectsThierry Wendling, Kayode Ogungbenro, Etienne Pigeolet, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 14, 2023
Exploring the Boundaries for In Vitro-In Vivo Extrapolation: Use of Isolated Rat Hepatocytes in Co-culture and Impact of Albumin Binding Properties in the Prediction of Clearance of Various Drug TypesLaura Francis, Kayode Ogungbenro, Tom De Bruyn, et al.
Pharmaceutical Research|October 16, 2010
A semi-mechanistic gastric emptying model for the population pharmacokinetic analysis of orally administered acetaminophen in critically ill patientsKayode Ogungbenro, Lakshmi Vasist, Robert Maclaren, et al.
British Journal of Clinical Pharmacology|October 22, 2009
Population pharmacokinetics and optimal design of paediatric studies for famciclovirKayode Ogungbenro, Ivan Matthews, Michael Looby, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Journal of Pharmacokinetics and Pharmacodynamics|January 9, 2009
Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial resultsMarylore Chenel, François Bouzom, Fanny Cazade, et al.
The AAPS Journal|November 6, 2015
Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical DataThierry Wendling, Nikolaos Tsamandouras, Swati Dumitras, et al.
Clinical Pharmacology and Therapeutics|September 16, 2017
Dose Rationalization of Pembrolizumab and Nivolumab Using Pharmacokinetic Modeling and Simulation and Cost AnalysisKayode Ogungbenro, Alkesh Patel, Robert Duncombe, et al.
The AAPS Journal|April 29, 2025
Simultaneous Estimation of fm and F<sub>G</sub> Values Directly from Clinical Drug-Drug Interaction Study DataYumi Cleary, Nicolo Milani, Kayode Ogungbenro, et al.
The AAPS Journal|May 16, 2025
Publisher Correction: Simultaneous Estimation of fm and FG Values Directly from Clinical Drug-Drug Interaction Study DataYumi Cleary, Nicolo Milani, Kayode Ogungbenro, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 13, 2005
Optimal blood sampling time windows for parameter estimation using a population approach: design of a phase II clinical trialMarylore Chenel, Kayode Ogungbenro, Vincent Duval, et al.
Pharmaceutical Research|November 27, 2014
Model-based evaluation of the impact of formulation and food intake on the complex oral absorption of mavoglurant in healthy subjectsThierry Wendling, Kayode Ogungbenro, Etienne Pigeolet, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 14, 2023
Exploring the Boundaries for In Vitro-In Vivo Extrapolation: Use of Isolated Rat Hepatocytes in Co-culture and Impact of Albumin Binding Properties in the Prediction of Clearance of Various Drug TypesLaura Francis, Kayode Ogungbenro, Tom De Bruyn, et al.
Pharmaceutical Research|October 16, 2010
A semi-mechanistic gastric emptying model for the population pharmacokinetic analysis of orally administered acetaminophen in critically ill patientsKayode Ogungbenro, Lakshmi Vasist, Robert Maclaren, et al.
British Journal of Clinical Pharmacology|October 22, 2009
Population pharmacokinetics and optimal design of paediatric studies for famciclovirKayode Ogungbenro, Ivan Matthews, Michael Looby, et al.
Pageof 10